- Home
- PRA vs TSHA Comparison
PRA vs TSHA Comparison
Compare PRA & TSHA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PRA
- TSHA
- Stock Information
- Founded
- PRA 1976
- TSHA 2019
- Country
- PRA United States
- TSHA United States
- Employees
- PRA N/A
- TSHA N/A
- Industry
- PRA Property-Casualty Insurers
- TSHA Biotechnology: Pharmaceutical Preparations
- Sector
- PRA Finance
- TSHA Health Care
- Exchange
- PRA Nasdaq
- TSHA Nasdaq
- Market Cap
- PRA 1.2B
- TSHA 1.4B
- IPO Year
- PRA N/A
- TSHA 2020
- Fundamental
- Price
- PRA $24.03
- TSHA $3.84
- Analyst Decision
- PRA Hold
- TSHA Strong Buy
- Analyst Count
- PRA 4
- TSHA 9
- Target Price
- PRA $21.00
- TSHA $10.22
- AVG Volume (30 Days)
- PRA 323.3K
- TSHA 4.1M
- Earning Date
- PRA 11-04-2025
- TSHA 11-04-2025
- Dividend Yield
- PRA N/A
- TSHA N/A
- EPS Growth
- PRA N/A
- TSHA N/A
- EPS
- PRA 0.66
- TSHA N/A
- Revenue
- PRA $1,120,385,000.00
- TSHA $6,310,000.00
- Revenue This Year
- PRA N/A
- TSHA N/A
- Revenue Next Year
- PRA N/A
- TSHA N/A
- P/E Ratio
- PRA $36.49
- TSHA N/A
- Revenue Growth
- PRA N/A
- TSHA N/A
- 52 Week Low
- PRA $13.00
- TSHA $1.05
- 52 Week High
- PRA $24.22
- TSHA $5.51
- Technical
- Relative Strength Index (RSI)
- PRA 54.55
- TSHA 37.78
- Support Level
- PRA $23.91
- TSHA $3.89
- Resistance Level
- PRA $24.06
- TSHA $4.55
- Average True Range (ATR)
- PRA 0.08
- TSHA 0.39
- MACD
- PRA -0.01
- TSHA -0.19
- Stochastic Oscillator
- PRA 51.92
- TSHA 8.99
About PRA ProAssurance Corporation
ProAssurance Corp is a holding company for property and casualty insurance companies. The company's wholly-owned insurance subsidiaries provide professional liability insurance for healthcare professionals and facilities, professional liability insurance for attorneys, and workers' compensation insurance. ProAssurance reports operating results in five segments: Specialty Property and Casualty, Workers' Compensation, Segregated Portfolio Cell Reinsurance, Lloyd's Syndicate, and Corporate. ProAssurance generates the vast majority of its revenue from its Specialty P&C activities, followed by Worker's Compensation.
About TSHA Taysha Gene Therapies Inc.
Taysha Gene Therapies Inc is a patient-centric gene therapy company to eradicate monogenic CNS disease. It is focused on developing and commercializing AAV-based gene therapies for the treatment of monogenic diseases of the CNS in both rare and large patient populations. The company develops and commercializes transformative gene therapy treatments. Its product pipeline includes, TSHA-102 which is a is a self-complementary intrathecally delivered AAV9 gene transfer therapy in clinical evaluation for Rett syndrome.